Bulldust (1248230) writes "Federal Court in Australia has ruled in favour of US biotechnology company Myriad Genetics enabling them to continue to hold the patent over the so-called breast cancer gene BRCA1. The same patent is also being reconsidered by the US Supreme Court in the current session." Link to Original Source
Sorry! There are no comments related to the filter you selected.